PH26687A - Antiretroviral furan ketones - Google Patents
Antiretroviral furan ketones Download PDFInfo
- Publication number
- PH26687A PH26687A PH39761A PH39761A PH26687A PH 26687 A PH26687 A PH 26687A PH 39761 A PH39761 A PH 39761A PH 39761 A PH39761 A PH 39761A PH 26687 A PH26687 A PH 26687A
- Authority
- PH
- Philippines
- Prior art keywords
- branched
- ketone
- compound
- methyl
- double bonds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/58—One oxygen atom, e.g. butenolide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/64—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28776288A | 1988-12-21 | 1988-12-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH26687A true PH26687A (en) | 1992-09-15 |
Family
ID=23104228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH39761A PH26687A (en) | 1988-12-21 | 1989-12-21 | Antiretroviral furan ketones |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0374886A3 (fr) |
| JP (1) | JPH02221269A (fr) |
| KR (1) | KR900009620A (fr) |
| CN (1) | CN1043711A (fr) |
| AU (1) | AU621434B2 (fr) |
| CA (1) | CA2005991A1 (fr) |
| DK (1) | DK650089A (fr) |
| FI (1) | FI896134A7 (fr) |
| HU (1) | HUT52492A (fr) |
| IL (1) | IL92796A0 (fr) |
| NO (1) | NO895158L (fr) |
| NZ (1) | NZ231856A (fr) |
| PH (1) | PH26687A (fr) |
| PT (1) | PT92633A (fr) |
| ZA (1) | ZA899742B (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA899743B (en) * | 1988-12-21 | 1990-09-26 | Merrell Dow Pharma | Antiretroviral aryloxy substituted furan ketones |
| US5665874A (en) * | 1989-01-17 | 1997-09-09 | John Hopkins University | Cancer related antigen |
| US5759791A (en) * | 1989-01-17 | 1998-06-02 | The Johns Hopkins University | Cancer related antigen |
| US5759837A (en) * | 1989-01-17 | 1998-06-02 | John Hopkins University | Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway |
| US5614551A (en) * | 1994-01-24 | 1997-03-25 | The Johns Hopkins University | Inhibitors of fatty acid synthesis as antimicrobial agents |
| US5981575A (en) * | 1996-11-15 | 1999-11-09 | Johns Hopkins University, The | Inhibition of fatty acid synthase as a means to reduce adipocyte mass |
| CN100395241C (zh) * | 2006-05-26 | 2008-06-18 | 中国科学院南海海洋研究所 | 一种降解呋喃二倍半萜角质海绵素及其制备方法和应用 |
| EP2581081A3 (fr) * | 2007-06-01 | 2013-07-31 | The Trustees Of Princeton University | Traitement d'infections virales par modulation de voies métaboliques de cellules hôtes |
| ES2481346B1 (es) * | 2012-12-26 | 2015-05-08 | Consejo Superior De Investigaciones Científicas (Csic) | Procedimiento de obtención de moléculas orgánicas útiles como nuevos agentes surfactantes. |
| EP4208450A1 (fr) * | 2020-09-03 | 2023-07-12 | Imperial College Innovations Limited | Tensioactifs |
| CN114163407B (zh) * | 2020-09-11 | 2023-10-24 | 中国科学院宁波材料技术与工程研究所 | 抑制或杀灭微生物的呋喃环类成分、含其的制品及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1104574A (fr) * | 1976-12-20 | 1981-07-07 | Roger A. Parker | Traduction non-disponible |
| FR2518999A1 (fr) * | 1981-12-28 | 1983-07-01 | Agrifurane Sa | Procede de preparation de composes cetoniques en particulier de composes furanniques ou composes cetoniques a longues chaines, composes furanniques et composes cetoniques a longues chaines prepares par mise en oeuvre dudit procede |
| US4801698A (en) * | 1986-08-15 | 1989-01-31 | Warner-Lambert Company | Process for preparing diaminopyrimido(4,5-d)pyrimidine glycoside and glycotide |
| ZA899743B (en) * | 1988-12-21 | 1990-09-26 | Merrell Dow Pharma | Antiretroviral aryloxy substituted furan ketones |
-
1989
- 1989-12-18 AU AU46930/89A patent/AU621434B2/en not_active Ceased
- 1989-12-19 IL IL92796A patent/IL92796A0/xx unknown
- 1989-12-19 ZA ZA899742A patent/ZA899742B/xx unknown
- 1989-12-19 CA CA002005991A patent/CA2005991A1/fr not_active Abandoned
- 1989-12-19 NZ NZ231856A patent/NZ231856A/en unknown
- 1989-12-20 HU HU896706A patent/HUT52492A/hu unknown
- 1989-12-20 FI FI896134A patent/FI896134A7/fi not_active Application Discontinuation
- 1989-12-20 KR KR1019890019004A patent/KR900009620A/ko not_active Withdrawn
- 1989-12-20 DK DK650089A patent/DK650089A/da not_active Application Discontinuation
- 1989-12-20 JP JP1330945A patent/JPH02221269A/ja active Pending
- 1989-12-20 NO NO89895158A patent/NO895158L/no unknown
- 1989-12-20 EP EP19890123559 patent/EP0374886A3/fr not_active Ceased
- 1989-12-20 PT PT92633A patent/PT92633A/pt not_active Application Discontinuation
- 1989-12-21 CN CN89109422A patent/CN1043711A/zh active Pending
- 1989-12-21 PH PH39761A patent/PH26687A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT92633A (pt) | 1990-06-29 |
| HU896706D0 (en) | 1990-02-28 |
| DK650089A (da) | 1990-06-22 |
| EP0374886A3 (fr) | 1992-01-02 |
| NO895158D0 (no) | 1989-12-20 |
| IL92796A0 (en) | 1990-09-17 |
| KR900009620A (ko) | 1990-07-05 |
| DK650089D0 (da) | 1989-12-20 |
| EP0374886A2 (fr) | 1990-06-27 |
| NO895158L (no) | 1990-06-22 |
| AU4693089A (en) | 1990-06-28 |
| NZ231856A (en) | 1991-05-28 |
| JPH02221269A (ja) | 1990-09-04 |
| CN1043711A (zh) | 1990-07-11 |
| CA2005991A1 (fr) | 1990-06-21 |
| FI896134A7 (fi) | 1990-06-22 |
| HUT52492A (en) | 1990-07-28 |
| AU621434B2 (en) | 1992-03-12 |
| FI896134A0 (fi) | 1989-12-20 |
| ZA899742B (en) | 1990-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69407032T2 (de) | Oligonucleotide mit amidverkettungen die phosphoesterverkettungen einsetzen | |
| NO326265B1 (no) | Sulfonamid-derivater som medisinforloper av aspartylproteaseinhibitorer | |
| DE69633680T2 (de) | Behandlung von zns-wirkungen des hiv mit vx-478, allein oder kombiniert mit azt oder 3tc | |
| US20250154190A1 (en) | Stereoselective technologies for chiral compounds | |
| Artico et al. | 3, 4-Dihydro-2-alkoxy-6-benzyl-4-oxopyrimidines (DABOs): a new class of specific inhibitors of human immunodeficiency virus type 1 | |
| CA2911376C (fr) | Derives de phenyle (sulfonylcarbamate) et compositions pharmaceutiques de ceux-ci pour le traitement de maladies liees a l'angiotensine | |
| PH26687A (en) | Antiretroviral furan ketones | |
| US20040266723A1 (en) | Antiviral agents for treatment of Flaviviridae infections | |
| KR20180067603A (ko) | Acc 억제제 및 그의 용도 | |
| JP2009102371A (ja) | 自己免疫疾患および炎症障害の処置のためのトリプトリドアナログ | |
| CS226182B2 (en) | Method of preparing 1-(p-methoxybenzoyl)-2-pyrrolidinone | |
| JP5278968B2 (ja) | 骨髄異形性症候群及び急性骨髄性白血病の治療のための組成物及び方法 | |
| EP1355887B1 (fr) | Derives d'acyclonucleosides pyrimidiniques, leur procede de preparation et leur utilisation | |
| EP0309952B1 (fr) | Esters de castanospermine antirétrovirales | |
| RU2139875C1 (ru) | Сульфаматы псевдофруктопиранозы и фармацевтическая композиция на их основе | |
| EP0328111B1 (fr) | Inhibiteurs de métastase de cellules cancéreuses | |
| KR20000065885A (ko) | 항바이러스성 피리미딘다이온 유도체 및 그 제조방법 | |
| WO2014084658A1 (fr) | Composition pour la prévention ou le traitement d'une maladie cardiaque | |
| HU228988B1 (hu) | Benzolszulfonil(tio)karbamidok alkalmazása béta-receptor blokkolókkal kombinálva | |
| CN112142716B (zh) | 一种5元杂芳基取代的吡嗪衍生物及其应用 | |
| KR0171190B1 (ko) | 신규 아스코르브산 유도체 | |
| US20040204394A1 (en) | Triptolide analogues | |
| CZ274495A3 (en) | Derivative of alkyl-5-methylsulfonyl benzoguanidine, process of its preparation and pharmaceutical composition containing thereof | |
| KR101718242B1 (ko) | Hiv 억제 활성을 가지는 신규한 화합물 및 이의 용도 | |
| EP0374885B1 (fr) | Cétones furanniques aryloxy substituées antirétrovirales |